NCI's invigorated effort to expedite benchtop to bedside technology development has benefited companies, but the collaborations aren't always easy. By Wendy Diller National Institutes of Health (NI
by Mark L. Ratner To protect their existing businesses and leverage into new markets, makers of diagnostic imaging equipment are combining imaging modalities and championing the use of new molecular p
Molecular imaging is progressing into the clinic, but as in the research world, a host of thorny questions has yet to be resolved before opportunities can be optimized. By Wendy Diller In February of